EU Medicines Regulation Achievements: EMA’...

By HEOR Staff Writer

March 16, 2026

The European Medicines Agency (EMA) Management Board highlights at its March 2026 meeting a robust year, with the adoption of the 2025 annual report...
Novartis Drug Discovery Innovation: Advancing Global Health Through Strategic...
NICE Updates Type 2 Diabetes Guidelines: Emphasizing Cardiorenal Protection w...
Advancing Cancer Screening in Slovenia: A Pathway to Equitable Care
Characterizing Burnout in Health Professionals: Insights from the BEATS Study...
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
Driving Economic Transformation through Brain Health Investment in Africa
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...